Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata
Conditions: Alopecia Areata Interventions: Drug: Methotrexate; Drug: Triamcinolone Acetonide Sponsors: Al-Azhar University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants
Conditions: Alopecia Areata (AA) Interventions: Drug: IMG-007 Sponsors: Inmagene LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials
First Patient Dosed in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
WALTHAM, Mass. and DUBLIN, Sept. 13, 2023. Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced that the first patient has been... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 13, 2023 Category: Pharmaceuticals Source Type: clinical trials
Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-Phase 2a Trial for the Treatment of Severe Alopecia Areata
Condition: Alopecia Areata Interventions: Drug: ADX-914; Drug: Placebo Sponsors: Q32 Bio Inc.; Innovaderm Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials
